Vascular type Ehlers-Danlos syndrome is associated with platelet dysfunction and low vitamin D serum concentration

Publikation: Beitrag in FachzeitschriftForschungsartikelBeigetragenBegutachtung

Beitragende

  • Albert Busch - , Universitätsklinikum Würzburg (Autor:in)
  • Sabine Hoffjan - , Ruhr-Universität Bochum (Autor:in)
  • Frauke Bergmann - , MVZ wagnerstibbe (Autor:in)
  • Birgit Hartung - , Universitätsklinikum Würzburg (Autor:in)
  • Helena Jung - , Universitätsklinikum Köln (Autor:in)
  • Daniela Hanel - , synlab MVZ Stuttgart GmbH (Autor:in)
  • Andreas Tzschach - , Institut für Klinische Genetik, UniversitätsCentrum für Seltene Erkrankungen (Autor:in)
  • Janos Kadar - , Universitätsklinikum Köln (Autor:in)
  • Yskert von Kodolitsch - , Medizinische Universität Graz (Autor:in)
  • Christoph-Thomas Germer - , Universitätsklinikum Würzburg (Autor:in)
  • Heiner Trobisch - , Laboratory and Ambulance for Coagulation Disorders (Autor:in)
  • Erwin Strasser - , Universitätsklinikum der Friedrich-Alexander-Universität Erlangen-Nürnberg (Autor:in)
  • René Wildenauer - , Universitätsklinikum Würzburg (Autor:in)

Abstract

BACKGROUND: The vascular type represents a very rare, yet the clinically most fatal entity of Ehlers-Danlos syndrome (EDS). Patients are often admitted due to arterial bleedings and the friable tissue and the altered coagulation contribute to the challenge in treatment strategies. Until now there is little information about clotting characteristics that might influence hemostasis decisively and eventually worsen emergency situations.

RESULTS: 22 vascular type EDS patients were studied for hemoglobin, platelet volume and count, Quick and activated partial thromboplastin time, fibrinogen, factor XIII, von Willebrand disease, vitamin D and platelet aggregation by modern standard laboratory methods. Results show a high prevalence of over 50 % for platelet aggregation disorders in vascular type EDS patients, especially for collagen and epinephrine induced tests, whereas the plasmatic cascade did not show any alterations. Additionally, more than half of the tested subjects showed low vitamin D serum levels, which might additionally affect vascular wall integrity.

CONCLUSION: The presented data underline the importance of detailed laboratory screening methods in vascular type EDS patients in order to allow for targeted application of platelet-interacting substances that might be of decisive benefit in the emergency setting.

Details

OriginalspracheEnglisch
Seiten (von - bis)111-119
Seitenumfang9
FachzeitschriftOrphanet Journal of Rare Diseases
Jahrgang11
Ausgabenummer1
PublikationsstatusVeröffentlicht - 3 Aug. 2016
Peer-Review-StatusJa

Externe IDs

Scopus 84988019869
PubMed 27488172
PubMedCentral PMC4971646

Schlagworte

Schlagwörter

  • Adult, Aged, Blood Coagulation/physiology, Blood Coagulation Tests, Blood Platelets/physiology, Ehlers-Danlos Syndrome/blood, Factor XIII/metabolism, Female, Fibrinogen/metabolism, Humans, Male, Middle Aged, Vitamin D/blood, Young Adult, von Willebrand Factor/metabolism